Ending U.S. Aid, Preserving the Alliance: Trump’s Israel Ruse

Donald Trump’s declaration on Election Day that the United States would end its approximately $4 billion in annual military assistance to Israel was immediately portrayed as a historic rupture in American-Israeli relations. Critics on the left saw a potential turning point; isolationists on the right welcomed an end to foreign handouts. But the announcement may represent something quite different. Rather than dismantling the strategic alliance, ending direct military grants could accelerate a transition toward a deeper, less visible form of military integration, one that embeds Israeli defense requirements more firmly within the American national security establishment.

The political timing was no accident. Speaking to Fox News on November 3, Trump complained that Democrats had turned military assistance to Israel into a political liability for Republicans, explicitly singling out Michigan Senate candidate Abdul El-Sayed. Calling the assistance a “bad talking point,” Trump presented its termination as a populist gesture that appealed to his America First constituency while removing a vulnerability in Republican electoral campaigns. His announcement was as much about American domestic politics as foreign policy.

For Prime Minister Benjamin Netanyahu, the arrangement offered a political opportunity. He had already advocated gradually phasing out American military assistance over a decade, presenting Israel as a sovereign technological power rather than a country dependent on foreign aid. Trump’s announcement let Netanyahu frame the move as a victory for Israeli self-reliance, even as the country’s defense establishment remained deeply dependent on American military technology, industrial capacity, and strategic support. On November 6, Netanyahu’s office described the change as a transition “from aid to partnership.”

To understand why this announcement may represent a structural shift rather than a strategic break, it is necessary to distinguish between ending direct financial assistance and ending military cooperation. Trump himself acknowledged that the United States would continue selling advanced weapons to Israel and would help it in the event of a crisis. The distinction is fundamental: terminating grants administered through the State Department does not necessarily mean reducing the flow of American weapons, technology, or institutional support.

For decades, Foreign Military Financing (FMF) has been the cornerstone of American security assistance. Under the 2016 Memorandum of Understanding negotiated by the Obama administration, Washington committed to providing Israel with $38 billion over ten fiscal years (2019–2028). This includes $33 billion in FMF grants and $5 billion for cooperative missile-defense programs. FMF is not simply cash transferred to the Israeli government. The grants are deposited in a Federal Reserve account and are largely restricted to purchases of American defense equipment and services. The arrangement therefore supports American defense manufacturers as well as Israeli military procurement.

Another distinctive feature was Offshore Procurement, which allowed Israel to spend a portion of its American military assistance on purchases from its own defense industry. The current MOU has systematically phased out that privilege, and it is scheduled to disappear by 2028. The existing arrangement was thus already moving toward greater integration with the American defense-industrial base before Trump’s announcement.

What is emerging is not necessarily a reduction in American support but an institutional migration: from conventional foreign military assistance toward Pentagon-administered research, development, procurement, and industrial cooperation.

The legislative dimension of this transition is already taking shape. In February 2026, bipartisan legislation was introduced in both chambers of Congress under the title United States-Israel Framework for Upgraded Technologies, Unified Research, and Enhanced Security (FUTURES) Act. Republican Congressman Ronny Jackson and Democratic Congressman Don Davis introduced the House bill, H.R. 7540. Its Senate companion, S. 3855, was introduced by Republican Senator Ted Budd and Democratic Senator Kirsten Gillibrand.

The FUTURES Act would establish a United States-Israel Defense Technology Cooperation Initiative within the Department of Defense. It authorizes $150 million annually for fiscal years 2027 through 2029 to accelerate joint research, development, testing, and integration of defense technologies. The bill covers counter-drone systems, missile and air defense, artificial intelligence, autonomous systems, directed energy, cyber defense, electronic warfare, and other emerging technologies. Particularly significant are provisions promoting joint ventures, licensing agreements, and U.S.-based co-production and manufacturing partnerships with Israeli industry.

The legislation remains pending in Congress, and its proposed funding should not be confused with an enacted appropriation. Nevertheless, it provides a concrete indication of the institutional direction of bilateral defense cooperation. Rather than simply purchasing American weapons with American grants, Israel would increasingly participate in the development of technologies intended for both countries’ military forces. The distinction between foreign assistance and shared defense-industrial investment becomes increasingly blurred.

The FUTURES Act is not the only legislative initiative pointing in this direction. Provisions in the proposed 2027 National Defense Authorization Act would also expand cooperation in defense technology and identify opportunities to integrate Israeli-developed capabilities into American military systems. Together, these initiatives suggest that the transition from traditional aid to a more integrated defense relationship is not merely a product of Trump’s announcement. It has a broader institutional and bipartisan foundation.

Existing programs offer precedents. Iron Dome, David’s Sling, and Arrow missile-defense systems have involved extensive American-Israeli cooperation, including joint research, development, and production. The FUTURES Act would extend this model into additional technological fields and provide a more formal Pentagon framework for such collaboration.

But this institutional transformation raises an important question of democratic accountability. Foreign Military Financing is a visible and identifiable instrument of American foreign policy. It appears in the foreign operations budget, is subject to congressional appropriations and debate, and operates within a statutory framework governing arms transfers and military assistance. The Leahy Laws, for example, restrict assistance to foreign security-force units implicated in gross human rights violations, while the Arms Export Control Act establishes requirements governing American arms transfers.

These mechanisms have never guaranteed that Washington would condition assistance on Israeli conduct. Successive administrations have demonstrated considerable reluctance to use American military aid as leverage over Israeli policies in the West Bank or Gaza. Nevertheless, the political and legal mechanisms for debating and challenging such assistance are identifiable.

Pentagon research and procurement programs operate under a different institutional logic. Their primary objectives are military readiness, technological superiority, and the strengthening of the American defense-industrial base. A joint research initiative or production agreement is not automatically subject to the same policy debate as an annual foreign military assistance appropriation. Nor does the existence of general arms-transfer and human-rights restrictions mean that every cooperative research or industrial project carries an equivalent mechanism for conditioning participation on the conduct of the Israeli government.

The distinction matters. Once bilateral cooperation is presented as essential to American technological superiority and military preparedness, attempts to connect it to Israeli policies toward Palestinians become politically and institutionally more difficult. The issue is not the absence of congressional oversight altogether. The FUTURES Act itself includes reporting requirements. Oversight instead takes place within a defense-industrial framework in which the central questions are likely to be technological performance, military utility, and industrial cooperation rather than the political consequences of American support for Israel.

Trump’s proposed timetable also raises serious questions. The existing MOU runs through September 2028, yet Trump declared that assistance would end by December 2026. The president cannot simply erase existing congressional appropriations, contractual obligations, or the legal and administrative arrangements governing military assistance. The abrupt announcement therefore leaves considerable uncertainty about outstanding weapons orders, multiyear contracts, appropriated funds, and the transition to a new framework.

The initial confusion among Israeli defense and finance officials, along with criticism from opposition leaders such as Gadi Eisenkot, who objected to learning about a potentially historic strategic change through American television, illustrates the problem. The announcement was dramatic, but the actual arrangements remain to be negotiated.

The ultimate paradox is that ending direct military assistance could make the American-Israeli defense relationship more resilient against political pressure rather than less consequential. Annual grants are visible, politically sensitive, and vulnerable to changes in congressional majorities and public opinion. Defense-industrial integration creates different constituencies: American contractors, research laboratories, universities, military planners, and congressional districts with an economic stake in continued cooperation. Once technologies, production lines, and procurement systems become intertwined, disengagement becomes considerably more complicated.

This is not to suggest that every dollar previously provided through FMF will automatically reappear through Pentagon programs or that Israel will escape the financial burden of purchasing its own weapons. The transition could involve real reductions in American subsidies. But the distinction between reducing direct aid and diminishing American military support is crucial.

Trump’s announcement therefore deserves to be examined less as the end of American assistance to Israel than as a possible reconfiguration of the relationship. The FUTURES Act, the proposed defense authorization provisions, and the existing network of joint weapons programs point toward a model in which American and Israeli defense establishments become more deeply interconnected.

The central question is not simply how much money Washington gives Israel each year. It is how American capital, technology, research, and institutional power will continue to flow into Israel’s defense establishment, through mechanisms that are less readily identified and debated as foreign assistance. The aid may disappear as a visible budgetary category. The strategic commitment, however, could become more deeply embedded than ever.